Overexpression of the epidermal growth factor receptor family in gastric cancer suggests a role in tumor pathogenesis

Digestive Surgery

Volumn 14, Issue 4, 1997, Pages 252-259

  Deflorin, Judith ^a   Friess, Helmut ^a   Schobinger, Stephan ^a   Bründler, Marie Anne ^a   Schilling, Martin ^a   Naef, Markus ^b   Korc, Murray ^b   Büchler, Markus W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

c erbB 2; c erbB 3; Epidermal growth factor receptor overexpression; Gastric cancer; Immunohistochemistry; Northern blot analysis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NORTHERN BLOTTING; PATHOGENESIS; RECEPTOR GENE; STOMACH CANCER;

EID: 0030751475     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000172554     Document Type: Editorial

References (45)

1. Levi F, Maisonneuve P, Filiberti R, La Veechia C, Boyle P: Cancer incidence and mortality in Europe, Soz Praventivmed 1989:34(suppl 2): 12-13.
2. Nakajima T, Nishi M, Kajitani T: Improvement in treatment results of gastric cancer with surgery and chemotherapy: Experience of 9.700 cases in the Cancer Institute Hospital, Tokyo, Semin Surg Oncol 1991;7:365-372.
3. Maruyama K: The most important prognostic factors for gastric cancer patients, Scand J Gastroenterol 1987;22(suppl 133):269-274.
4. Yarden Y, Ullrich A: Growth factor tyrosine kinases, Annu Rev Biochcm 1988:57:443-463.
5. Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity, Cell 1990;61:203-212.
6. Yamanaka Y, Friess H, Biichler MW, Kobrin MS, Beger HG, Kore M: Cocxprcssion of epidermal growth factor receptor and ligands is associated with enhanced aggressiveness of human pancreatic cancer, Anticancer Res 1993: 13:565-570.
7. Kore M, Chandrasekar B, Yamanaka Y, Friess H, Biichler MW, Beger HG: Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increase in the levels of epidermal growth factor and transforming growth factor alpha, J Clin Invest 1992:90:1352-1360.
8. Yamanaka Y, Friess H, Kobrin MS, Biichler MW, Kunz J, Beger G, Kork M: Overexpression of HER/neu oncogene in human pancreatic carcinoma, Hum Pathol 1993;24:1127-1134.
9. Friess H, Yamanaka Y, Biichler MW, Ebert M, Beger HG, Gold LI, Kore M: Enhanced expression of transforming growth I'aclor-beta isoforms in pancreatic cancer correlates with decreased survival, Gastroenterology 1993:105: 1846-1856.
10. Friess H, Yamanaka Y, Biichler MW, Beger HG, Kobrin MS, Baldwin RL, Kore M: Enhanced expression ofthe type II transforming growth factor-beta receptor in human pancreatic cancer cells without alteration of type III receptor expression, Cancer Res 1993;53: 2704-2707.
11. Casey G, Yamanaka Y, Friess H, Kobrin MS, Lopez ME, Biichler MW, Beger HG, Kore M: p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis, Cancer Lett 1993:69:151-160.
12. Wright C, Angus B, Nicholson C: Expression of c-crbB-2 oncoprotein: A prognostic indicator in human breast cancer, Cancer Res 1989:49: 2087-2090.
13. Prigent SA, Lemoine NR: The type 1 (EGFR-rclatcd) family of growth factor receptors and their ligands, Prog Growth Factor Res 1992;4: 1-24.
14. Prigenl SA, Lemoine NR, Hughes CM, Plowman GD, Selden C, Gullick WJ: Expression of the c-erbB-3 protein in normal human adult and fetal tissues, Oncogene 1992:7:1273-1278.
15. Lemoine NR, Jain S, Silvestre F, Lopes C, Hughes CM, McLelland E, Gullick WJ, Filipc Ml: Amplification and overcxprcssion of the EGFR and crbB-2 proto-oncogene in human stomach cancer, Br J Cancer 1991;64:79-83.
16. Tsujino T, Yoshida K, Nadayama H, lto H, Shimosato T, Tahara E: Alterations of oncogenes in metastatic tumours of human gastric carcinomas, Br J Cancer 1990:62:226-230.
17. Pinotek M, Hengels KJ: EGF-Rezeptor und Magenkarzinom, Z Gastroenterol 1993:31:18-20.
18. Sakai K, Mori S, Kawamoto T, Taniguchi S, Kobori O, Morioka Y: Expression of epidermal growth factor receptors on normal human gastric cpithelia and gastric carcinomas, J Natl Cancer Inst 1986;77:1047-1052.
19. Yasui W, Sumiyoshi H, Mata J, Kameda T, Ochiai A, Ito H: Expression of epidermal growth factor receptor in human gastric and colonic carcinomas, Cancer Res 1988:48:137-141.
20. Yonemura Y, Sugiyama K, Fujimura T, Kama-ta T, Fushida S, Yamaguchi A: Epidermal growth factor receptor status and S-phase fractions in gastric carcinoma, Oncology 1989:46: 158-161.
21. Yonemura Y, Ninomiya I, Yamaguchi A, Fushida S, Kimura H, Ohoyama S, Miyazaki I, Endon Y, Tanaka N, Sasaki T: Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short-term prognosis in gastric cancer, Cancer Res 1991:51:1034-1038.
22. Ranzani GN, Pellegata NS, Provider C, Sara-goni A, Vio A, Maltoni M, Amadori D: Heterogenous proto-oncogene amplification correlates with tumor progression and presence of metastascs in gastric cancer patients, Cancer Res 1990:50:7811-7814.
23. Park JB, Rhim JS, Park SC, Kimm SW. Kraus Mil: Amplification, overcxprcssion and rearrangement of the erbB-2 proto-oncogene in primary human stomach carcinomas, Cancer Res 1989:49:6605-6609.
24. Kraus MH, Issing W, Miki T, Popcscu NC, Aaronson SA: Isolation and characterization of ERBB3. a third member of the ERBB/cpidcr-mal growth factor receptor family: Evidence for overcxprcssion in a subset of human mammary tumors, Proc Natl Acad Sci USA 1989:86: 9193-9197.
25. Fricss H, Yamanaka Y, Kork M, Biichler MW: Overcxprcssion of c-crbB-3 in human pancreatic cancer: Correlation with tumor aggressiveness, Clin Cancer Res 1995; 1:1413-1420.
26. Sliwkowski MX, Schaefer G, Akita RW, Lof-gren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Ccrionc RA, Vandlcn RL, Carraway KL III: Cocxprcssion of crbB2 and erbB3 proteins reconstitutes a high-alfinity receptor for hereg-ulin, J Biol Chem 1994;296:14661-14665.
27. King CR, Borrello I, Bellot F, Comoglio P, Schlcssinger J: EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the crbB-2 protein in the mammary tumour cell line SK-BR-3. EMBO J 1988:7:1647-1651.
28. Kokai Y, Dobashi K, Weiner DB, Myers JN, Nowell PC, Green MI: Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular ncu (NGL) gene products, Proc Natl Acad Sci USA 1988.85: 5389-5393.
29. Stern DF, Kamps MP, Can H: Oncogenic activation of pI85neu stimulates tyrosine phosphorylation in vivo, Mol Cell Biol 1988:8: 3969-3973.
30. Ullrich A, Coussens L, Havfiiek JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libcrmann TA, Schlcssinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH: Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells, Nature 1986:309:418-425.
31. Baldwin RL, Kore M: Growth inhibition of human pancreatic carcinoma cells by transforming growth factor bcta-1. Growth Factors 1993;8:23-34.
32. Balmain A, Krumlauf R, Vass JK, Bimic GD: Cloning and characterization of the abundant cytoplasmic 7S RNA from mouse cells, Nucleic Acids Res 1982:10:4259-4277.
33. Feinberg AP, Vogelstein B; A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity, Anal Bio-chcni 1983;132:6-13.
34. Chomezynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocya-nate-phenol-chloroform extraction, Anal Bio-chem 1987:162:156-159.
35. Korc M, Owerbach D, Quinto C, Rutter WJ: Pancreatic islet-acinar cell interaction: Amylase messenger RNA levels are determined by insulin, Science 1981;213:351-353.
36. Yamanaka Y, Friess H, Biichler MW, Beger HG, Gold LI, Kore M: Synthesis and expression of transforming growth factor betal, beta2. and beta3 in the endocrine and exocrine pancreas, Diabetes 1993:2:746-756.
37. Fricss H, Yamanaka Y, Biichler MW, Beger HG, Do DA, Kobrin MS, Kore M: Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis, Am J Pathol 1994;144:117-128.
38. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI: Immunohistochemical localization of TGF-PL TGF-p2. and TGF-p3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development, J Cell Biol 1991;115:1091-1105.
39. Siegel S: Nonparametric Statistics for Behavioral Sciences, New York, McGraw-Hill, 1956.
40. Jain S, Filipc MI, Gullick WJ: c-erbB-2 proto-oncogene expression and its relationship to survival in gastric carcinoma: An immunohisto-chcmical study on archival material, Int J Cancer 1991;48:668-671.
41. Rilke F, Colnaghi ML, Cascinell N: Prognostic significance of HFR-2/neu expression in breast cancer and its relationship to other prognostic factors, Int J Cancer 1991:49:44-49.
42. DePotter CR, Beghin C, Makar AP: The neu oncogene protein as a predictive factor for hac-matogenous metastases in breast cancer patients, Int J Cancer 1990;45:44-49.
43. Berger MS, Locher GW, Saurer S: Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading, Cancer Res 1988;48:1238-1243.
44. Slamon DJ, Godolphin W, Jones IA, Holt JA, Wong SG, Keith DE, Stuart SG, Udove J, Ullrich A, Press MF: Studies of the HER-2/neu protc-oncogenc in human breast and ovarian cancer, Science 1989:244:707-712.
45. Kokai Y, Myers JN, Wasa T, Brown VI, LeVea CM, Davis JG, Dobashi K, Greene Ml: Synergistic interaction of pl85c-neu and the EGF receptor leads to transformation of rodent fibroblasts, Cell 1989:58:287-292.